词条 | Cytochalasin E |
释义 |
| Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 363722351 | Reference = [1] | ImageFile=Cytochalasin E.png | IUPACName= | OtherNames= |Section1={{Chembox Identifiers | CASNo_Ref = {{cascite|correct|??}} | CASNo=36011-19-5 | PubChem=5458385 | ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | ChemSpiderID = 4572350 | InChI = 1/C28H33NO7/c1-16-9-8-12-19-23-27(4,35-23)17(2)21-20(15-18-10-6-5-7-11-18)29-24(31)28(19,21)36-25(32)34-14-13-26(3,33)22(16)30/h5-8,10-14,16-17,19-21,23,33H,9,15H2,1-4H3,(H,29,31)/b12-8+,14-13+/t16-,17-,19-,20-,21-,23-,26+,27+,28+/m0/s1 | InChIKey = LAJXCUNOQSHRJO-ZYGJITOWBM | StdInChI_Ref = {{stdinchicite|changed|chemspider}} | StdInChI = 1S/C28H33NO7/c1-16-9-8-12-19-23-27(4,35-23)17(2)21-20(15-18-10-6-5-7-11-18)29-24(31)28(19,21)36-25(32)34-14-13-26(3,33)22(16)30/h5-8,10-14,16-17,19-21,23,33H,9,15H2,1-4H3,(H,29,31)/b12-8+,14-13+/t16-,17-,19-,20-,21-,23-,26+,27+,28+/m0/s1 | StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} | StdInChIKey = LAJXCUNOQSHRJO-ZYGJITOWSA-N | EINECS = 252-835-7 | SMILES=C[C@H]1C/C=C/[C@H]2[C@H]3[C@](O3)([C@H]([C@@H]4[C@]2(C(=O)N[C@H]4CC5=CC=CC=C5)OC(=O)O/C=C/[C@@](C1=O)(C)O)C)C |Section2={{Chembox Properties | C=28 | H=33 | N=1 | O=7 | Appearance= | Density=1.309 g/ml | MeltingPt= | BoilingPt= | Solubility= |Section3={{Chembox Hazards | MainHazards=Toxic | EUClass = T+ | FlashPt= | AutoignitionPt = | RPhrases = {{R26/27/28}} {{R63}} | SPhrases = {{S28}} {{S36/37}} {{S45}} }} Cytochalasin E, a member of the cytochalasin group, is an inhibitor of actin polymerization in blood platelets. It inhibits angiogenesis and tumor growth. Unlike cytochalasin A and cytochalasin B, it does not inhibit glucose transport. Because of its antiangiogenic effect, cytochalasin E is a potential drug for age-related macular degeneration, a kind of blindness caused by an abnormal proliferation of blood vessels in the eye.[2] Cytochalasin E was found to be a potent and selective inhibitor of bovine capillary endothelial (BCE) cell proliferation. Cytochalasin E differs from other cytochalasin molecules by having an epoxide, which is required for specificity and potency. Cytochalasin E is a potent antiangiogenic agent that may be useful for treatments of cancer and other pathologic angiogenesis.[3] References1. ^Cytochalasin E from Aspergillus clavatus at Sigma-Aldrich 2. ^eyesight.org {{webarchive|url=https://web.archive.org/web/20060519050124/http://www.eyesight.org/Research/Research-Cytochalasin_E/research-cytochalasin_e.html |date=2006-05-19 }} 3. ^{{cite journal | pmid = 10900214 | volume=294 | title=Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth | date=August 2000 | journal=J. Pharmacol. Exp. Ther. | pages=421–7 | last1 = Udagawa | first1 = T | last2 = Yuan | first2 = J | last3 = Panigrahy | first3 = D | last4 = Chang | first4 = YH | last5 = Shah | first5 = J | last6 = D'Amato | first6 = RJ}} External pagesCytochalasin E from FermentekCytochalasin E from Cayman Chemical{{biochemistry-stub}} 5 : Mycotoxins|Actin inhibitors|Carbonate esters|Epoxides|Lactones |
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。